Nasal Drug Delivery Market Size (2022-2030) Share, Industry Trends, Growth, Challenges, and Forecast: Growth Plus Reports

 | Source: Growth Plus Reports Growth Plus Reports

Pune, Oct. 27, 2022 (GLOBE NEWSWIRE) -- According to the latest report published by Growth Plus Reports, the global nasal drug delivery market is expected to clock US$ 108.33 billion by 2030 and to grow at a CAGR of 6.1% during the forecast period.  This exclusive information is published by Growth Plus Reports in its report titled “Nasal Drug Delivery Market – Global Outlook & Forecast 2022-2030”

The nasal drug delivery system delivers local and systemic medications that use the nasal cavity (nose) as a route of administration. This kind of drug delivery system offers numerous benefits, including a quick impact and a practical approach. Due to the faster drug absorption via the nasal epithelium's high permeability, which avoids hepatic first-pass metabolism and membrane, it is an alternate option for the oral drug delivery system.

Download PDF Brochure of Nasal Drug Delivery Market Size - COVID-19 Impact and Global Analysis with Strategic Developments at: https://growthplusreports.com/inquiry/request-sample/nasal-drug-delivery-market/7901

Market Drivers

The market for nasal drug delivery is rather large and is anticipated to develop steadily throughout the projected period. The market is expanding due to the increased incidence of COPD (chronic obstructive pulmonary disease) and asthma, changing patient preferences, and rising public demand for nasal drug delivery systems. Developing technical improvements like smart nasal medication delivery systems, increased self-administrative drug consumption, and high accessibility contribute to the market rise. Furthermore, growing R&D activities and enhancing focus on nasal drug delivery system designs also contribute to the market growth.

The nasal drug delivery market has been analyzed from four perspectives: Type, application, distribution channel, and region.

Excerpts from ‘By Type Segmentation’

The types in the nasal drug delivery market have been divided into:

  • Nebulizers
  • Metered Dose Inhalers
  • Dry Powder Inhalers

Dry powder inhalers generate the majority of market income. The stability of the product, the ability to provide low or large dosages based on needs, and its low sensitivity to microbes are a few of the aspects that may be credited with the segment's rise. Metered dose inhalers also have a considerable market position. The benefits of metered dose inhalers, such as the capacity to give multiple doses, reduced drug/dose loss, and convenience in use, support the steady demand for metered dose inhalers. Furthermore, it provides a constrained and determined drug amount, may be utilized for pressured metered dosages, and does not necessitate the pre-preparation of pharmaceuticals.

Excerpts from ‘By Region Segmentation’

The global nasal drug delivery market has been segmented into:

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

North America holds the largest revenue share in the market. The existence of cutting-edge technology, a developed healthcare infrastructure, and an increase in R&D activities contribute to market development. In addition, the rise in respiratory illness, the use of nasal drug delivery systems, and an increase in nasal vaccination procedures. Due to the rising incidence of infections, asthma, etc., Europe ranks second in revenue share. The Asia Pacific is a developing regional market because of the growing senior population, expanding healthcare infrastructure, rising vaccination rates, and many other factors. The demand for nasal medication delivery is also developing due to increasing R&D activity and rising healthcare spending.

Speak to our Analyst to Understand the Impact of COVID-19 on Your Business: https://growthplusreports.com/inquiry/speak-analyst/nasal-drug-delivery-market/7901

Excerpts from ‘Competitive Landscape’

Some prominent players operating in the nasal drug delivery market are

  • Gofire Inc.
  • 3M Co.
  • Teva Pharmaceutical Industries Ltd.
  • Nemera France SAS
  • AptarGroup Inc.
  • H&T Presspart Manufacturing Ltd.
  • Consort Medical Plc.
  • Vectura Group Limited
  • Merck & Co. Inc.
  • Johnson & Johnson Services Inc.
  • GSK plc.
  • Pfizer Inc.

Table of Content

  1. INTRODUCTION
    1. Market Ecosystem 
    2. Timeline Under Consideration
      1. Historical Years – 2020
      2. Base Year – 2021
      3. Forecasted Years – 2022 to 2030
    3. Currency Used in the Report
  2. RESEARCH METHODOLOGY 
    1. Research Approach
    2. Data Collection Methodology
    3. Data Sources
      1. Secondary Sources 
      2. Primary Sources 
    4. Market Estimation Approach
      1. Bottom Up 
      2. Top Down 
    5. Market Forecasting Model
    6. Limitations and Assumptions       
  3. PREMIUM INSIGHTS
    1. Current Market Trends (COVID-19 Perspective)
    2. Key Players & Competitive Positioning (2021)
  4. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
  5. GLOBAL NASAL DRUG DELIVERY MARKET- ANALYSIS & FORECAST, BY TYPE
    1. Nebulizer
    2. Metered Dose Inhaler
    3. Dry Powder Inhaler
  6. GLOBAL NASAL DRUG DELIVERY MARKET- ANALYSIS & FORECAST, BY APPLICATION
    1. Asthma
    2. Chronic Obstructive Pulmonary Disease (COPD)
    3. Nasal Congestion
    4. Rhinitis
    5. Vaccination
  7. GLOBAL NASAL DRUG DELIVERY MARKET- ANALYSIS & FORECAST, BY DISTRIBUTION CHANNEL
    1. Hospitals and Clinics
    2. Retail Pharmacies
    3. Online Pharmacies

TOC Continued…

VALUE PROPOSITIONS RELATED TO THE REPORT:

  • Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
  • Comprehensive quantitative and qualitative insights at segment and sub-segment level
  • Covid 19 impact trends and perspective
  • Granular insights at global/regional/country level
  • Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
  • Blanket coverage on competitive landscape
  • Winning imperatives
  • Exhaustive coverage on 'Strategic Developments' registered by leading players of the market

CUSTOMIZATION OPTIONS:

  • Distributor Landscape Assessment
  • Pricing Intelligence
  • Customer Base Assessment
  • Investment & Initiatives Analysis
  • 'Business Profile' of Key Players

Directly Purchase Premium Copy of Nasal Drug Delivery Market Growth Report (2022-2030) at: https://growthplusreports.com/checkout?_token=JnROTnndiKLZbUHJuPGma1iwEjDenDTp62AJJgqE&report_id=7901&license=Single

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.

 

            








        

            

                

                    
Tags

                            
                                Nasal Drug Delivery Market
                            
                            
                                Nasal Drug Delivery Outlook
                            
                            
                                Nasal Drug Delivery Share
                            

                



        




    

        

        
Contact Data